Corrigendum to 'Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study': [ESMO Open Volume 7, Issue 2, April 2022, 100466]
ESMO Open. 2022 Jun;7(3):100523.
doi: 10.1016/j.esmoop.2022.100523.
Epub 2022 Jun 10.